SOUTH SAN FRANCISCO, Calif., May 1 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) will announce financial results for the first quarter of 2008 after the markets close on Thursday, May 8, 2008 and will hold a webcast teleconference at 4:30 p.m. EDT that day. Members of Anesiva's management team will discuss financial results from the first quarter and will provide an overview of the company's product pipeline, recent events and milestones.
Interested parties can listen to the live audio webcast by dialing (866) 616-3642 (international dial: 706-643-3817) or by logging on to http://www.anesiva.com and going to the Investor Information page. For those unable to participate via the Internet, a 24-hour replay will be available for seven days after the call by dialing (800) 642-1687 (international dial: 706-645-9291) and giving the following pass code: 45132379. The webcast will be available until the company's next quarterly financial results conference call.
About Anesiva and its Diverse Pipeline of Pain Products
Anesiva, Inc. is a late-stage biopharmaceutical company that seeks to
be the leader in the development and commercialization of novel
pharmaceutical products for pain management. The company has one
FDA-approved product, Zingo(TM), for the reduction of pain associated with
peripheral venous access procedures in children ages three to 18. In
clinical trials, the most common adverse reactions to Zingo were redness
(erythema), red dots (petechiae) and swelling (edema). The second product
in Anesiva's pipeline, Adlea(TM), reduces pain after only a single
administration for weeks to months based on mid-stage clinical trials for
site-specific, acute and chroni
|SOURCE Anesiva, Inc.|
Copyright©2008 PR Newswire.
All rights reserved